Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-01-31 Purchase |
2024-02-02 4:32 pm |
Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner |
5,206,074 | $2.31 | $12,026,031 | 9,729,505 (Indirect) |
View |
2023-08-29 Purchase(A) |
2023-08-31 11:26 am |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
881,000 | $0.0187 | $16,475 | 30,272,724 (Indirect Direct) |
View |
2023-08-29 Purchase |
2023-08-29 6:39 pm |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
881,000 | $0.0187 | $16,475 | 43,807,874 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-02-29 Option Award(A) |
2024-03-04 06:15 am |
N/A 2034-03-01 |
Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer |
100,000 | $0 | 284,738 (Direct) |
View |
2024-02-29 Option Award(A) |
2024-03-04 06:13 am |
N/A 2034-03-01 |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
225,000 | $0 | 522,006 (Direct) |
View |
2024-02-29 Option Award |
2024-03-01 6:42 pm |
N/A 2034-03-01 |
Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer |
100,000 | $0 | 285,738 (Direct) |
View |
2024-02-29 Option Award |
2024-03-01 6:24 pm |
N/A 2034-03-01 |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
225,000 | $0 | 522,006 (Direct) |
View |
2024-01-31 Option Award |
2024-02-02 4:35 pm |
N/A N/A |
Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner |
5,206,074 | $2.31 | 9,729,505 (Indirect) |
View |
2023-11-06 Option Award |
2023-11-06 8:32 pm |
N/A 2033-08-25 |
Skye Bioscience Inc. | SKYE | Ward Keith Wayne Director |
14,110 | $0 | 20,001 (Direct) |
View |
2023-11-06 Option Award |
2023-11-06 8:30 pm |
N/A 2033-08-25 |
Skye Bioscience Inc. | SKYE | Charych Deborah H. Director |
14,110 | $0 | 20,001 (Direct) |
View |
2023-11-06 Option Award |
2023-11-06 8:29 pm |
N/A 2033-08-25 |
Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer |
160,262 | $0 | 231,174 (Direct) |
View |
2023-11-06 Option Award |
2023-11-06 8:29 pm |
N/A 2033-08-25 |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
215,856 | $0 | 327,605 (Direct) |
View |
2023-11-06 Option Award |
2023-11-06 8:29 pm |
N/A 2033-08-25 |
Skye Bioscience Inc. | SKYE | DALESANDRO MARGARET Director |
14,110 | $0 | 20,001 (Direct) |
View |
2023-11-06 Option Award |
2023-11-06 8:29 pm |
N/A N/A |
Skye Bioscience Inc. | SKYE | Grayson Paul A. Director |
173,721 | $0 | 246,252 (Direct) |
View |
2023-11-06 Option Award |
2023-11-06 8:29 pm |
N/A 2033-08-25 |
Skye Bioscience Inc. | SKYE | TYLE PRAVEEN Director |
14,110 | $0 | 20,001 (Direct) |
View |
2023-11-06 Option Award |
2023-11-06 8:29 pm |
N/A 2033-08-25 |
Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director |
14,110 | $0 | 20,001 (Direct) |
View |
2023-08-25 Option Award(A) |
2023-08-31 11:26 am |
N/A 2033-08-25 |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
22,530,460 | $0 | 30,272,724 (Direct) |
View |
2023-08-28 Acquisition(A) |
2023-08-31 11:26 am |
N/A N/A |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
110,000 | $0.0171 | 30,272,724 (Direct) |
View |
2023-08-23 Acquisition(A) |
2023-08-31 11:26 am |
N/A N/A |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
9,000 | $0.0118 | 30,272,724 (Direct) |
View |
2023-08-25 Option Award |
2023-08-29 9:36 pm |
N/A 2033-08-25 |
Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director |
1,472,692 | $0 | 1,472,692 (Direct) |
View |
2023-08-25 Option Award |
2023-08-29 7:25 pm |
N/A N/A |
Skye Bioscience Inc. | SKYE | Grayson Paul A. Director |
18,132,596 | $0 | 18,132,596 (Direct) |
View |
2023-08-25 Option Award |
2023-08-29 6:53 pm |
N/A 2033-08-25 |
Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer |
16,727,648 | $0 | 17,727,648 (Direct) |
View |
2023-08-25 Option Award |
2023-08-29 6:39 pm |
N/A 2033-08-25 |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
22,530,460 | $0 | 43,807,874 (Direct) |
View |
2023-08-28 Acquisition |
2023-08-29 6:39 pm |
N/A N/A |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
110,000 | $0.0171 | 43,807,874 (Direct) |
View |
2023-08-23 Acquisition |
2023-08-29 6:39 pm |
N/A N/A |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
9,000 | $0.0118 | 43,807,874 (Direct) |
View |
2023-08-25 Option Award |
2023-08-29 6:22 pm |
N/A 2033-08-25 |
Skye Bioscience Inc. | SKYE | TYLE PRAVEEN Director |
1,472,692 | $0 | 1,472,692 (Direct) |
View |
2023-08-25 Option Award |
2023-08-29 6:21 pm |
N/A 2033-08-25 |
Skye Bioscience Inc. | SKYE | DALESANDRO MARGARET Director |
1,472,692 | $0 | 1,472,692 (Direct) |
View |
2023-08-25 Option Award |
2023-08-29 6:17 pm |
N/A 2033-08-25 |
Skye Bioscience Inc. | SKYE | Ward Keith Wayne Director |
1,472,692 | $0 | 1,472,692 (Direct) |
View |
2023-08-25 Option Award |
2023-08-29 6:02 pm |
N/A 2033-08-25 |
Skye Bioscience Inc. | SKYE | Charych Deborah H. Director |
1,472,692 | $0 | 1,472,692 (Direct) |
View |
Ownership |
2023-08-28 4:18 pm |
N/A N/A |
Skye Bioscience Inc. | SKYE | 5AM Partners VII LLC 5AM Ventures VII L.P. 5AM Partners II LLC 5AM Ventures II LP 5AM CO-INVESTORS II LP DIEKMAN JOHN D PARMAR KUSH ROCKLAGE SCOTT M 10% Owner |
0 | $0 | 1,557,205,277 (Indirect) |
View |
Ownership |
2023-08-28 4:16 pm |
N/A N/A |
Skye Bioscience Inc. | SKYE | Versant Ventures III LLC Versant Venture Capital III L.P. Versant Side Fund III L.P. 10% Owner |
0 | $0 | 632,737,156 (Indirect) |
View |
2023-08-18 Option Award |
2023-08-22 5:21 pm |
2023-08-18 2033-08-18 |
Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner |
704,509,037 | $0 | 443,296,919 (Indirect) |
View |
2023-08-18 Option Award |
2023-08-22 5:21 pm |
N/A N/A |
Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner |
852,696,240 | $0.0103 | 443,296,919 (Indirect) |
View |
2023-02-22 Option Award |
2023-03-17 2:52 pm |
N/A N/A |
Skye Bioscience Inc. | SKYE | Emerald Health Sciences Inc. 10% Owner |
41,379,164 | $0.0386 | 178,549,387 (Direct) |
View |
2023-02-22 Option Award |
2023-03-17 2:52 pm |
N/A N/A |
Skye Bioscience Inc. | SKYE | Emerald Health Sciences Inc. 10% Owner |
16,641,486 | $0.017 | 178,549,387 (Direct) |
View |
2022-11-10 Other |
2023-03-17 2:52 pm |
2023-11-10 2024-12-30 |
Skye Bioscience Inc. | SKYE | Emerald Health Sciences Inc. 10% Owner |
9,141,486 | $0 | 178,549,387 (Direct) |
View |
2023-02-14 Option Award |
2023-02-16 5:30 pm |
N/A 2033-02-14 |
Skye Bioscience Inc. | SKYE | Charych Deborah H. Director |
250,000 | $0 | 250,000 (Direct) |
View |
2023-01-05 Option Award(A) |
2023-01-09 11:28 am |
N/A 2033-01-05 |
Skye Bioscience Inc. | SKYE | TYLE PRAVEEN Director |
250,000 | $0 | 250,000 (Direct) |
View |
2023-01-05 Option Award |
2023-01-09 11:23 am |
N/A 2033-01-05 |
Skye Bioscience Inc. | SKYE | DALESANDRO MARGARET Director |
250,000 | $0 | 250,000 (Direct) |
View |
2023-01-05 Option Award |
2023-01-09 10:42 am |
N/A 2033-01-05 |
Skye Bioscience Inc. | SKYE | Ward Keith Wayne Director |
250,000 | $0 | 250,000 (Direct) |
View |
2023-01-05 Option Award |
2023-01-09 10:30 am |
N/A 2033-01-05 |
Skye Bioscience Inc. | SKYE | Rai Sukhwinder Singh Director |
250,000 | $0.017 | 250,000 (Direct) |
View |
2023-01-05 Option Award |
2023-01-06 5:21 pm |
N/A 2033-01-05 |
Skye Bioscience Inc. | SKYE | TYLE PRAVEEN Director |
250,000 | $0 | 250,000 (Direct) |
View |
2022-11-10 Option Award |
2022-11-15 1:41 pm |
N/A 2024-04-03 |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
5,302,264 | $0 | 8,302,264 (Direct) |
View |